Financials data is unavailable for this security.
View more
Year on year Race Oncology Ltd had net income fall 39.26% from a loss of 9.92m to a larger loss of 13.82m despite a 40.68% increase in revenues from 591.84k to 832.58k.
Gross margin | -- |
---|---|
Net profit margin | -1,659.82% |
Operating margin | -1,659.82% |
Return on assets | -58.97% |
---|---|
Return on equity | -63.10% |
Return on investment | -63.04% |
More ▼
Cash flow in AUDView more
In 2024, cash reserves at Race Oncology Ltd fell by 4.33m. Cash Flow from Financing totalled 5.21m or 625.60% of revenues. In addition the company used 9.55m for operations while cash from investing was breakeven.
Cash flow per share | -0.0823 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.1075 |
---|---|
Tangible book value per share | 0.091 |
More ▼
Balance sheet in AUDView more
Current ratio | 9.32 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼